
Europe Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, and Others); Application (Knee, Hips and Others); and End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Academic & Research Institutes) and Country
Market Introduction
Degeneration of cartilage can lead to pain and chronic inflammation in joints of the human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damaged cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.

Get more information on this report :
Market Overview and Dynamics
The Europe cartilage degeneration market is expected to reach US$ 3,365.09 million by 2027 from US$ 2,463.16 million in 2019; it is anticipated to grow at a CAGR of 4.1% from 2020 to 2027. The increasing prevalence of sports injuries and obesity is expected to boost the growth of the cartilage degeneration market in Europe. However, the market growth is impacted by the high cost of cartilage therapies and lack of reimbursement scenario.
Key Market Segments
In terms of procedure type, the joint replacement segment accounted for the largest share of the Europe cartilage degeneration market in 2019. In terms of application, the knee segment accounted for the largest share of the Europe cartilage degeneration market in 2019. Based on end user, the hospitals & specialty clinics segment accounted for the largest share of the Europe cartilage degeneration market in 2019.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Asia Pacific cartilage degeneration market are the World Health Organization (WHO), British Journal of Sports Medicine, European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA), Organization for Economic Cooperation and Development (OECD), and others.
Reasons to buy report
- Understand the Europe cartilage degeneration market landscape and identify segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape in the region
- Efficiently plan mergers and acquisitions, and partnership deals in the Europe cartilage degeneration market by identifying segments with the most promising probable sales
- Take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments
- Obtain revenue forecast of market based on various segments for the preiod 2019–2027
Europe Cartilage Degeneration Market Segmentation
By Procedure Type
- Joint Replacement
- Chondroplasty
- Cell-based Cartilage Resurfacing
- Osteochondral Transplant
- Meniscus Transplants
- Others
By Application
- Knee
- Hips
- Others
By End User
- Hospitals & Specialty Clinics
- Ambulatory Surgical Centers
- Academic & Research Institutes
By Country
- Germany
- UK
- France
- Italy
- Spain
Company Profiles
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Cartilage Degeneration Market – By Procedure Type
1.3.2 Europe Cartilage Degeneration Market – By Application
1.3.3 Europe Cartilage Degeneration Market– By End User
1.3.4 Europe Cartilage Degeneration Market – By Country
2. Europe Cartilage Degeneration Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Cartilage Degeneration Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cartilage Degeneration Market - Europe PEST Analysis
4.3 Expert Opinion
5. Europe Cartilage Degeneration Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Sports Injuries
5.1.2 Increasing Prevalence of Obesity
5.2 Key Market Restraints
5.2.1 High Cost of Cartilage Repair Therapies
5.3 Key Market Opportunities
5.3.1 Growing Number of Product Approvals and Developments
5.4 Future Trends
5.4.1 Rising Emphasis on Regenerative Medicines
5.5 Impact analysis
6. Cartilage Degeneration Market – Europe Analysis
6.1 Europe Cartilage Degeneration Market Revenue Forecasts and Analysis
7. Europe Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Procedure Type
7.1 Overview
7.2 Europe Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)
7.2.1 Europe Cartilage Degeneration Market Revenue and Forecasts to 2027, By Procedure Type (US$ Mn)
7.3 Osteochondral Transplant
7.3.1 Overview
7.3.2 Europe Osteochondral Transplant Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Chondroplasty
7.4.1 Overview
7.4.2 Europe Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Joint Replacement
7.5.1 Overview
7.5.2 Europe Joint Replacement Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Meniscus Transplants
7.6.1 Overview
7.6.2 Europe Meniscus Transplants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Cell-based Cartilage Resurfacing
7.7.1 Overview
7.7.2 Europe Cell-based Cartilage Resurfacing Market Revenue and Forecast to 2027 (US$ Mn)
7.8 Other Procedures
7.8.1 Overview
7.8.2 Europe Other Procedures Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 Europe Cartilage Degeneration Market, By Application 2019 & 2027 (%)
8.2.1 Europe Cartilage Degeneration Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Knee
8.3.1 Overview
8.3.2 Europe Knee Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hip
8.4.1 Overview
8.4.2 Europe Hip Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Other Applications
8.5.1 Overview
8.5.2 Europe Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Cartilage Degeneration Market Analysis – By End-User
9.1 Overview
9.2 Europe Cartilage Degeneration Market, By End-User 2019-2027 (%)
9.2.1 Europe Cartilage Degeneration Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Hospitals and Specialty Centres
9.3.1 Overview
9.3.2 Europe Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Ambulatory Surgical Centres
9.4.1 Overview
9.4.2 Europe Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Europe Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
10. Cartilage degeneration Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Europe Cartilage degeneration Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Europe: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.4 Europe: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.5 Europe: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 Europe: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
10.1.7 Germany: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Germany: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Germany: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 France: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 France: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 France: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 France: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.8.4 France: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 UK: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 UK: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 UK: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 UK: Cartilage Degeneration Market, Application – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 UK: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.10 Italy: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Italy: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Italy: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.10.3 Italy: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.10.4 Italy: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.11 Spain: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Spain: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Spain: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Spain: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Spain: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Cartilage degeneration Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 B. Braun Melsungen AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Smith & Nephew
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Stryker Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 CartiHeal, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vericel Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Cartilage Degeneration Market Revenue and Forecasts To 2027, By Procedure Type (US$ Mn)
Table 2. Europe Cartilage Degeneration Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. Europe Cartilage Degeneration Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 4. Europe: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Europe: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. Europe: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Germany: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 9. Germany: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 10. France: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 11. France: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 12. France: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 13. UK: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 14. UK: Cartilage Degeneration Market, Application – Revenue and Forecast to 2027 (USD Million)
Table 15. UK: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Italy: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Italy: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 18. Italy: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Spain: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Spain: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 21. Spain: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 22. Glossary of Terms, Cartilage Degeneration Market
LIST OF FIGURES
Figure 1. Cartilage Degeneration Market Segmentation
Figure 2. Europe Cartilage Degeneration Market Overview
Figure 3. Knee Segment Held Largest Share of Cartilage Degeneration Market
Figure 4. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Europe Cartilage Degeneration Market - Leading Country Markets (US$ Mn)
Figure 6. Cartilage Degeneration Market - Europe PEST Analysis
Figure 7. Cartilage Degeneration Market Impact Analysis of Driver and Restraints
Figure 8. Europe Cartilage Degeneration Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Europe Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)
Figure 10. Europe Osteochondral Transplant Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Europe Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Europe Joint Replacement Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Europe Meniscus Transplants Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Europe Cell-based Cartilage Resurfacing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Europe Other Procedures Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Europe Cartilage Degeneration Market, By Application 2019 & 2027 (%)
Figure 17. Europe Knee Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Europe Hip Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Europe Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Europe Cartilage Degeneration Market, by End-User 2019 & 2027 (%)
Figure 21. Europe Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Europe Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Europe Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Europe: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. Europe: Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)
Figure 26. Europe: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
Figure 27. Germany: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. France: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. UK: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Italy: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Spain: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in Europe Country Markets
The List of Companies - Europe Cartilage Degeneration Market
- B. Braun Melsungen AG
- Smith & Nephew
- Stryker Corporation
- CartiHeal, Inc
- Vericel Corporation